Fate Therapeutics adopts amended indemnification agreements for directors and officers

FATE THERAPEUTICS INC

Board approved amended form of indemnification agreement effective August 26, 2024.
Revised change-of-control definition and added coverage of separate counsel expenses in change of control.
Advancement of defense expenses clarified to be irrespective of insurance coverage.
Includes express presumption of good faith in favor of Indemnitee (burden on challenger).
Indemnitee may seek specific performance without showing irreparable harm.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.